Importantly, we believe that the KDM6A-TLE1-HES1 regulatory axis we defined makes a valuable contribution to the understanding of epigenetic deregulation in bladder cancer with regard to the mutations observed in KDM6A. The gene discussed is HES1; the disease is urinary bladder carcinoma.